Previous article
Thinking Through Testing for Primary Thyroid Disease
Sep 2025
Next article
RSV Vaccination During Pregnancy Improves Infant Outcomes
Medicine by the Numbers

Parenteral Agents for Mitigating Migraine Relapse

Brit Long, MD
Michael Gottlieb, MD

American Family Physician. 2025;112(3):254-257.

Author disclosure: No relevant financial relationships.

BRIT LONG, MD, University of Virginia School of Medicine, Charlottesville

MICHAEL GOTTLIEB, MD, Rush University Medical Center, Chicago, Illinois

Address correspondence to Brit Long, MD, at brit.long@yahoo.com.

Author disclosure: No relevant financial relationships.

  1. 1.International Headache Society. International Classification of Headache Disorders 3rd Edition (ICHD-3). Accessed September 21, 2020. https://ichd-3.org/
  2. 2.Friedman BW. Migraine in the emergency department. Neurol Clin. 2019;37(4):743-752.
  3. 3.Wijeratne T, Kuan WS, Kelly AM, et al.; HEAD Study Group. Migraine in the emergency department. Neuroepidemiology. 2022;56(1):32-40.
  4. 4.American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1-18.
  5. 5.Orr SL, Aubé M, Becker WJ, et al. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 2015;35(3):271-284.
  6. 6.Vinson DR, Hurtado TR, Vandenberg JT, et al. Variations among emergency departments in the treatment of benign headache. Ann Emerg Med. 2003;41(1):90-97.
  7. 7.Friedman BW, West J, Vinson DR, et al. Current management of migraine in US emergency departments. Cephalalgia. 2015;35(4):301-309.
  8. 8.Yang S, Orlova Y, Lipe A, et al. Trends in the management of headache disorders in US emergency departments. J Clin Med. 2022;11(5):1401.
  9. 9.Ducharme J, Beveridge RC, Lee JS, et al. Emergency management of migraine: is the headache really over? Acad Emerg Med. 1998;5(9):899-905.
  10. 10.Friedman BW, Solorzano C, Esses D, et al. Treating headache recurrence after emergency department discharge. Ann Emerg Med. 2010;56(1):7-17.
  11. 11.Colman I, Friedman BW, Brown MD, et al. Parenteral dexamethasone for acute severe migraine headache. BMJ. 2008;336(7657):1359-1361.
  12. 12.Schellenberg ES, Dryden DM, Pasichnyk D, et al.; Agency for Healthcare Research and Quality. Acute migraine treatment in emergency settings. Comparative effectiveness review no 84. November 2012. Accessed July 21, 2025. https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research.pdf
  13. 13.Rice JB, White AG, Scarpati LM, et al. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther. 2017;39(11):2216-2229.
  14. 14.Colman I, Brown MD, Innes GD, et al. Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature. Ann Emerg Med. 2005;45(4):393-401.
  15. 15.Colman I, Brown MD, Innes GD, et al. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ. 2004;329(7479):1369-1373.
  16. 16.Friedman BW, Kapoor A, Friedman MS, et al. The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. Ann Emerg Med. 2008;52(6):705-713.
  17. 17.Taggart E, Doran S, Kokotillo A, et al. Ketorolac in the treatment of acute migraine: a systematic review. Headache. 2013;53(2):277-287.
  18. 18.Chaimani A, Caldwell DM, Li T, et al. Undertaking network meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al., eds. Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane; 2024. Accessed August 2025. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-11
  19. 19.Watt J, Tricco AC, Straus S, et al. Research techniques made simple: network meta-analysis. J Invest Dermatol. 2019;139(1):4-12.e1.
  20. 20.Kirkland S, Meyer J, Visser L, et al. The effectiveness of parenteral agents to mitigate relapses after severe acute migraine headache presentations: a systematic review and network analysis. Headache. 2024;64(10):1181-1199.
  21. 21.Loder E, Weizenbaum E, Frishberg B, et al.; American Headache Society Choosing Wisely Task Force. Choosing Wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question. Headache. 2013;53(10):1651-1659.
  22. 22.Worthington I, Pringsheim T, Gawel MJ, et al.; Canadian Headache Society Acute Migraine Treatment Guideline Development Group. Canadian Headache Society guideline: acute drug therapy for migraine headache. Can J Neurol Sci. 2013;40(5 suppl 3):S1-S80.

Copyright ©2026 MD Aware, LLC (theNNT.com). Used with permission.

This series is coordinated by Christopher W. Bunt, MD, AFP assistant medical editor, and the NNT Group.

A collection of Medicine by the Numbers published in AFP is available at https:// www.aafp.org/afp/mbtn.

Previous article
Thinking Through Testing for Primary Thyroid Disease
Sep 2025
Next article
RSV Vaccination During Pregnancy Improves Infant Outcomes

Current issue

May 2026

May 2026

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.